Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

SHE:002550 Revenue

Changzhou Qianhong Biopharma CO.,LTD had revenue of 358.08M CNY in the quarter ending March 31, 2026, a decrease of -20.58%. This brings the company's revenue in the last twelve months to 1.48B, down -2.48% year-over-year. In the year 2025, Changzhou Qianhong Biopharma CO.,LTD had annual revenue of 1.57B with 2.95% growth.

• Revenue (ttm): 1.48B
• Revenue Growth: -2.48%
• P/S Ratio: 6.01
• Revenue / Employee: 1.51M
• Employees: 979
• Market Cap: 8.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.57B	45.03M	2.95%
Dec 31, 2024	1.53B	-288.03M	-15.88%
Dec 31, 2023	1.81B	-489.28M	-21.24%
Jan 1, 2023	2.30B	428.61M	22.86%
Jan 1, 2022	1.87B	207.33M	12.43%